Page 47 - P4403.14-V110 November OTC Magazine 2025 NI
P. 47

EARS & EYES & MOUTH 47








                                           Clinically





                                                proven





                                           to speed



                      Save

                 Up               Off                                              1
                 To19%

                     Trade                    healing



























                                                               Aciclovir





               Reference: 1. Haleon data on file 2007.
               Product Information: Zovirax Cold Sore Cream (Aciclovir). Indications: For the treatment of Herpes simplex virus infections of the lips and face.
               Legal category: GSL. License Holder: Haleon UK trading Limited, The Heights, Weybridge , Surrey, KT13 0NY, United Kingdom. Information about this product,
               including adverse reactions, precautions, contra-indications and method of use can be found at: https://www.medicines.org.uk/emc/product/27/smpc
               Trade marks are owned by or licensed to the Haleon group of companies. PM-GB-ZOV-24-00010






                                                                         Buying        Trade
                      Product                                     Size    Price/  RRP  Offer   POR    Pip Code
                                                                                              %
                                                                         Single         %
                      ZOVIRAX
                             ZOVIRAX CREAM 5 %W/W 1X 2G_PMP_UK-GSK  2g    £4.68  £9.69  19%  42%    2225225
                               ZOVIRAX CREAM 5 %W/W 1X2G UK X 12 SRP  2g  £4.46  £9.20  19%  42%     81208










                                                                                                                 07/10/2025   16:59:36
         P4403.14-V110 November OTC Magazine 2025 NI.indd   47
         P4403.14-V110 November OTC Magazine 2025 NI.indd   47                                                   07/10/2025   16:59:36
   42   43   44   45   46   47   48   49   50   51   52